Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-11-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2009-11-19Clinical Trial Update: Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm [Phase 4]
Phase 4 clinical trial update investigating predictors of response to antipsychotics using a treatment algorithm.
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 [Phase 3]
Extension study update for patients successfully treated with ziprasidone in a Phase 3 trial for schizophrenia; study completed with results…
-
CLINICAL_TRIALS research · 2009-11-13Clinical Trial Update: Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating huperzine-A for cognitive and functional impairments in patients with schizophrenia.
-
FDA approval · 2009-11-12FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for GEODON (ziprasidone) from Viatris Specialty LLC, updating the product’s labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-02Clinical Trial Update: Antipsychotic Polypharmacy: Prevalence, Background and Consequences [NA]
A completed study examining how common antipsychotic polypharmacy is in schizophrenia, with discussion of background context and potential c…
-
CLINICAL_TRIALS trial_result · 2009-10-26Clinical Trial Update: Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) [Phase 4]
A Phase 4 large simple trial assessing the cardiovascular safety of ziprasidone versus olanzapine in people with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone [Phase 4]
Phase 4 clinical trial evaluating patient satisfaction after switching schizophrenia patients from risperidone to paliperidone; results post…
-
CLINICAL_TRIALS trial_result · 2009-10-20Clinical Trial Update: Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia [Phase 4]
Phase 4 clinical trial comparing risperidone alone versus risperidone plus low-dose haloperidol for schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2009-10-19Clinical Trial Update: A Study for Patients With Schizophrenia [Phase 2]
A Phase 2 clinical trial for schizophrenia sponsored by Eli Lilly and Company has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-16Clinical Trial Update: An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia [NA]
An exploratory open-label trial evaluating adjunctive L-lysine therapy for schizophrenia has completed. Sponsor: Göteborg University.
-
CLINICAL_TRIALS trial_result · 2009-10-12Clinical Trial Update: Acceptance and Commitment Therapy for Delusions [NA]
This entry reports the completion of a clinical trial evaluating Acceptance and Commitment Therapy for delusions in people with schizophreni…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of three fixed doses (25 mg eq., 100 mg eq., and 150 mg eq.) of paliperidone palmitate…
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine [Phase 3]
Phase 3 study evaluating a therapy to prevent weight gain in patients treated with olanzapine. The trial assessed safety and efficacy, with …
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry [Phase 4]
A Phase 4 clinical trial evaluating quetiapine extended-release for managing psychotic aggression or agitation in adults with schizophrenia …
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Aripiprazole Treatment of the Prodrome [NA]
The clinical trial evaluating aripiprazole for prodromal schizophrenia/psychosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Medication Adherence in Older Adults With Serious Mental Illness [NA]
The entry reports completion of a clinical trial evaluating medication adherence in older adults with serious mental illness, including schi…
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
This clinical trial update reports on changes in auditory verbal hallucinations in patients with schizophrenia treated with atypical antipsy…
-
CLINICAL_TRIALS research · 2009-09-16Clinical Trial Update: Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
This document provides an update on a clinical trial investigating EEG changes in schizophrenia patients treated with atypical antipsychotic…
-
FDA approval · 2009-09-14FDA Approved: HALOPERIDOL LACTATE — Original Application (Mylan Institutional LLC)
FDA approved the original application for HALOPERIDOL LACTATE from Mylan Institutional LLC, authorizing a generic injectable form of haloper…
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Study of Mental Care in Spain
AstraZeneca-supported clinical trial in Spain studying mental care for schizophrenia has completed.
-
FDA approval · 2009-09-04FDA Approved: RISPERIDONE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for risperidone, a generic antipsychotic, authorizing its manufacturing and mar…
-
FDA approval · 2009-08-31FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company. The action concerns the ZYPREXA Z…
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia [Phase 2]
Phase 2 study evaluating the safety and efficacy of Study Drug versus placebo for negative symptoms in schizophrenia; the trial has complete…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia [Phase 3]
Phase 3 study comparing rapid-acting intramuscular olanzapine to placebo in agitated patients with schizophrenia; results have been posted.